Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
Author:
do Nascimento Tatiana A.12, Nogami Patricia Y.23, de Oliveira Camille F.1ORCID, Neto Walter F. F.1, da Silva Carla P.1, Ribeiro Ana Claudia S.1, de Sousa Alana W.1, Freitas Maria N. O.1ORCID, Chiang Jannifer O.12ORCID, Silva Franko A.1, das Chagas Liliane L.1, Carvalho Valéria L.12ORCID, Azevedo Raimunda S. S.12ORCID, Vasconcelos Pedro F. C.24, Costa Igor B.23ORCID, Costa Iran B.3ORCID, Barbagelata Luana S.3, das Chagas Junior Wanderley D.3, da Penha Junior Edvaldo T.3, Soares Luana S.3ORCID, Viana Giselle M. R.5, Amarilla Alberto A.6ORCID, Modhiran Naphak6ORCID, Watterson Daniel678, Casseb Lívia M. N.12ORCID, Martins Lívia C.12ORCID, Henriques Daniele F.12
Affiliation:
1. Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ananindeua 67030-000, Pará, Brazil 2. Graduate Program in Virology, Evandro Chagas Institute, Ananindeua 67030-000, Pará, Brazil 3. Department of Virology, Evandro Chagas Institute, Ananindeua 67030-000, Pará, Brazil 4. Department of Biological and Health Sciences, University of Pará State, Belém 66087-670, Pará, Brazil 5. Malaria Basic Research Laboratory, Parasitology Section, Evandro Chagas Institute, Health Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua 67000-000, Pará, Brazil 6. School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia 7. The Australian Institute for Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD 4072, Australia 8. Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia
Abstract
Several technological approaches have been used to develop vaccines against COVID-19, including those based on inactivated viruses, viral vectors, and mRNA. This study aimed to monitor the maintenance of anti-SARS-CoV-2 antibodies in individuals from Brazil according to the primary vaccination regimen, as follows: BNT162b2 (group 1; 22) and ChAdOx1 (group 2; 18). Everyone received BNT162b2 in the first booster while in the second booster CoronaVac, Ad26.COV2.S, or BNT162b2. Blood samples were collected from 2021 to 2023 to analyze specific RBD (ELISA) and neutralizing antibodies (PRNT50). We observed a progressive increase in anti-RBD and neutralizing antibodies in each subsequent dose, remaining at high titers until the end of follow-up. Group 1 had higher anti-RBD antibody titers than group 2 after beginning the primary regimen, with significant differences after the 2nd and 3rd doses. Group 2 showed a more expressive increase after the first booster with BNT162B2 (heterologous booster). Group 2 also presented high levels of neutralizing antibodies against the Gamma and Delta variants until five months after the second booster. In conclusion, the circulating levels of anti-RBD and neutralizing antibodies against the two variants of SARS-CoV-2 were durable even five months after the 4th dose, suggesting that periodic booster vaccinations (homologous or heterologous) induced long-lasting immunity.
Funder
the Public Ministry of Labor through the Research Support and Development Foundation National Institute of Science and Technology in Emerging and Reemerging Viruses Instituto Evandro Chagas, Ministry of Health—Brazil University of Queensland—Australia
Reference47 articles.
1. Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding;Lu;Lancet,2020 2. Queiroz, M.A.F., Santiago, A.M., de Brito, W.B., Pereira, K.A.S., de Brito, W.B., da Silva Torres, M.K., da Costa Lopes, J., dos Santos, E.F., da Costa, F.P., and de Sarges, K.M.L. (2023). Polymorphisms in the MBL2 Gene Are Associated with the Plasma Levels of MBL and the Cytokines IL-6 and TNF-α in Severe COVID-19. Front. Immunol., 14. 3. Rodrigues, F.B.B., da Silva, R., Santos, E.F.d., de Brito, M.T.F.M., da Silva, A.L.S., de Meira Leite, M., Póvoa da Costa, F., de Nazaré do Socorro de Almeida Viana, M., de Sarges, K.M.L., and Cantanhede, M.H.D. (2023). Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population. Viruses, 15. 4. Properties of Coronavirus and SARS-CoV-2;Malik;Malays. J. Pathol.,2020 5. Chilamakuri, R., and Agarwal, S. (2021). COVID-19: Characteristics and Therapeutics. Cells, 10.
|
|